Evidence map›Paper›PMID 38337749›Full record

ArticleNutrients2024

Correction: Ammar et al. Protective Effects of Naringenin from

Naglaa M Ammar, Heba A Hassan, Heba M I Abdallah, Sherif M Afifi, Abdelbaset M Elgamal, Abdel Razik H Farrag, Abd El-Nasser G El-Gendy, Mohamed A Farag, Abdelsamed I Elshamy

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Naglaa M AmmarTherapeutic Chemistry Department, Pharmaceutical and Drugs Research Institute, National Research Centre, Giza 12622, Egypt.
Heba A HassanTherapeutic Chemistry Department, Pharmaceutical and Drugs Research Institute, National Research Centre, Giza 12622, Egypt.
Heba M I AbdallahPharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza 12622, Egypt.
Sherif M AfifiPharmacognosy Department, Faculty of Pharmacy, University of Sadat City, Sadat City 32897, Egypt.
Abdelbaset M ElgamalChemistry of Microbial and Natural Products Department, Pharmaceutical and Drugs Research Institute, National Research Centre, Giza 12622, Egypt.ORCID 0000-0001-7060-0077
Abdel Razik H FarragDepartment of Pathology, Medical Research and Clinical Studies Institute, National Research Centre, Giza 12622, Egypt.
Abd El-Nasser G El-GendyMedicinal and Aromatic Plants Research Department, Pharmaceutical and Drugs Research Institute, National Research Centre, Cairo 12622, Egypt.ORCID 0000-0002-2435-7448
Mohamed A FaragPharmacognosy Department, College of Pharmacy, Cairo University, Cairo 11562, Egypt.ORCID 0000-0001-5139-1863
Abdelsamed I ElshamyChemistry of Natural Compounds Department, Pharmaceutical and Drugs Research Institute, National Research Centre, Giza 12622, Egypt.ORCID 0000-0003-3302-3623
National Research Centre · EGUniversity of Sadat City · EGZhejiang A & F University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID38337749
PMCPMC10857019
OpenAlexW4391360171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.